Copilot
Your everyday AI companion
Bing found these results
  1. Nexium, Priosec, and PrevAcid Mass Tort Litigation …

    Web5 days ago · Further, two defendants, AstraZeneca and Pfizer, had also changed course, and now supported consolidation. There are 34 tag-along actions in addition to the 161 cases consolidated by the Panel. US …

  2. FibroGen, Kind Pharma settle trade secrets theft dispute

  3. Prilosec Lawsuits Update 2024: A Controversial PPI Medication

  4. People also ask
    Lawsuits have previously been pursued against the drug makers for failing to warn about these risks, but settlements have been reached to resolve most claims.. In October 2023, AstraZeneca announced a Nexium and Prilosec settlement, in which the drug maker agreed to pay $425 million to resolve about 11,000 lawsuits.
    AstraZeneca will pay $425 million to settle approximately 11,000 allegations, the majority of which were filed by users who claimed the medications caused kidney damage, particularly chronic renal disease, and that the company neglected to warn of the hazards associated with their use.
    At the time, it cited the small number of filings (only 15), the differing heartburn drugs involved and the need to protect trade secrets among the various defendants. Since then, the size of the litigation has grown. Further, two defendants, AstraZeneca and Pfizer, had also changed course, and now supported consolidation.
    In Prilosec lawsuits, AstraZeneca was accused of mass tort for negligence in alerting physicians and patients about the fatal adverse effects of the acid reflux medication Prilosec.
  5. Class Action Lawsuit on Prevacid (Apr 2024 Update) - Schmidt

  6. Nexium, Prilosec and Other Acid Reflux Drug Lawsuits

  7. Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

  8. Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP et al

  9. Sanofi agrees to resolve 4,000 Zantac claims in state courts

  10. Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

  11. AstraZeneca sues Arkansas to block drug-discount program